Endpoints in stem cell trials in ischemic heart failure
Marko Banović(University of Belgrade), Jozef Bartúnek(Onze Lieve Vrouwziekenhuis Hospital), André Terzic(Mayo Clinic), Atta Behfar(Mayo Clinic), Andreas M. Zeiher(Goethe University Frankfurt), Marc Vanderheyden(Onze Lieve Vrouwziekenhuis Hospital), Zlatibor Lončar, Marco Metra(GoHypersonic (United States)), Branko Beleslin(University of Belgrade)
Cited by 17
Related Papers
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
|European Journal of Heart Failure|2012|2.6k
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2023|2.2k